THER-14. SMALL MOLECULE INHIBITOR TARGETING SELF-RENEWAL AS A THERAPEUTIC OPTION FOR RECURRENT MEDULLOBLASTOMA

Medulloblastoma (MB) is the most common pediatric brain tumor malignancy, and one of the leading causes of childhood cancer mortality. Often associated with tumor recurrence, relapsed MB patients are limited to palliation outwith the paucity of clinical trials available, carrying a mortality rate ap...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Adile, Ashley, Bakhshinyan, David, Venugopal, Chitra, Subapanditha, Minomi, Weetall, Marla, Davis, Thomas, Singh, Sheila
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Translational Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477256/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz036.221
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars